Arcus Biosciences, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US03969F1093
USD
25.26
-0.37 (-1.44%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
258.00
117.00
112.00
382.88
77.52
15.00
8.35
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
258.00
117.00
112.00
382.88
77.52
15.00
8.35
Raw Material Cost
10.00
16.00
14.00
7.06
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.00
2.00
2.00
0.26
0.00
0.00
0.00
Selling and Distribution Expenses
110.00
101.00
90.00
65.23
38.01
21.65
9.90
Other Expenses
44.40
33.80
28.60
25.61
15.93
7.85
4.96
Total Expenditure (Excl Depreciation)
568.00
457.00
392.00
328.63
197.36
100.13
59.55
Operating Profit (PBDIT) excl Other Income
-310
-340
-280
54.2
-119.80000000000001
-85.1
-51.2
Other Income
52.00
41.00
16.00
0.66
1.38
4.00
5.26
Operating Profit (PBDIT)
-248.00
-283.00
-250.00
61.96
-118.47
-81.13
-45.93
Interest
4.00
2.00
2.00
0.26
0.00
0.00
0.00
Exceptional Items
-20.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
248.00
101.00
98.00
375.82
0.00
0.00
0.00
Depreciation
10.00
16.00
14.00
7.06
4.39
3.58
3.66
Profit Before Tax
-282.00
-301.00
-266.00
54.65
-122.86
-84.71
-49.59
Tax
1.00
6.00
1.00
1.81
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-283.00
-307.00
-267.00
52.83
-122.86
-84.71
-49.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-283.00
-307.00
-267.00
52.83
-122.86
-84.71
-49.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-283.00
-307.00
-267.00
52.83
-122.86
-84.71
-49.59
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
485.00
462.00
657.00
841.45
502.30
163.84
234.94
Earnings per share (EPS)
-3.14
-4.15
-3.71
0.71
-2.24
-1.93
-1.43
Diluted Earnings per share
-3.14
-4.15
-3.71
0.71
-2.24
-1.93
-1.43
Operating Profit Margin (Excl OI)
-120.16%
-290.6%
-250.0%
14.17%
-160.27%
-591.39%
-656.76%
Gross Profit Margin
-105.43%
-243.59%
-225.0%
16.12%
-152.83%
-540.88%
-549.86%
PAT Margin
-109.69%
-262.39%
-238.39%
13.8%
-158.49%
-564.73%
-593.73%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 120.51% vs 4.46% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 7.82% vs -14.98% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 7.41% vs -21.80% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 100.00% vs 0.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Arcus Biosciences, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
258.00
28.83
229.17
794.90%
Other Operating Income
0.00
0.00
0.00
Total Operating income
258.00
28.83
229.17
794.90%
Raw Material Cost
10.00
97.00
-87.00
-89.69%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.00
0.00
4.00
Selling and Distribution Expenses
110.00
79.34
30.66
38.64%
Other Expenses
44.40
16.73
27.67
165.39%
Total Expenditure (Excl Depreciation)
568.00
343.60
224.40
65.31%
Operating Profit (PBDIT) excl Other Income
-310.00
-314.77
4.77
1.52%
Other Income
52.00
113.57
-61.57
-54.21%
Operating Profit (PBDIT)
-248.00
-104.20
-143.80
-138.00%
Interest
4.00
0.00
4.00
Exceptional Items
-20.00
0.80
-20.80
-2,600.00%
Gross Profit (PBDT)
248.00
-68.17
316.17
463.80%
Depreciation
10.00
97.00
-87.00
-89.69%
Profit Before Tax
-282.00
-200.40
-81.60
-40.72%
Tax
1.00
-37.54
38.54
102.66%
Provisions and contingencies
0
0
0.00
Profit After Tax
-283.00
-162.86
-120.14
-73.77%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-283.00
-162.86
-120.14
-73.77%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-283.00
-162.86
-120.14
-73.77%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
485.00
1,056.08
-571.08
-54.08%
Earnings per share (EPS)
-3.14
-0.55
-2.59
-470.91%
Diluted Earnings per share
-3.14
-0.55
-2.59
-470.91%
Operating Profit Margin (Excl OI)
-120.16%
-1,091.69%
0.00
971.53%
Gross Profit Margin
-105.43%
-358.60%
0.00
253.17%
PAT Margin
-109.69%
-564.83%
0.00
455.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 25.80 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 120.51% vs 4.46% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit -28.30 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 7.82% vs -14.98% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -30.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 7.41% vs -21.80% in Dec 2023

Annual - Interest
Interest 0.40 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 100.00% vs 0.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -120.16%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023